FDA Investigator Michelle M Noe Varga

Michelle M Noe Varga has conducted inspections on 238 sites in 9 countries as of 19 Sep 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
238
Last Inspection Date:
19 Sep 2022
Investigator Role:
FDA Investigator
Redica ID:
100005390
Countries of Inspections:
France, United States of America, Germany, Finland, Canada, Hungary, South Africa, India, Poland
FDA Investigators that have inspected at least one site in common with Michelle M Noe Varga:
Aaron L Morris, Abby E Pelletier, Aimee Cunningham, PhD, Aldo J Quintana, Alexandra B Pitkin, Alice C Silva, Allen F Hall, Allison A Rodriguez, Almaris N Alonso, Alois P Provost, Alysia M Salonia, Amanda E Lewin, PhD, Amber G Wardwell, Amy C Jordan, Amy Devlin, PhD, Andrea A Branche, Andrew M Barlow, Andrew P Abban, Anissa M Cheung, Anne E Carpenter, Anthony C Warchut, Anthony N Onianwa, Anthony P Costello, Anthony W Thomas, Arie C Menachem, Ashley M Whitehurst, Asia D Clark, Atricia L Irons, Betsy C Galliher, Bill Tacket, Jr, Bradley D Newsad, Brenda P King, Brenna L Macdowell, Brentley S Collins, Bruce R Ota, Burnell M Henry, Byungja E Marciante, Carl A Huffman, III, Carla C Tuite, Cassandra L Abellard, CDR Jeremy L Wally, PhD, Charles Yuanchia Kuo, PhD, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christine L Williams, Christine M Whitby, CSO, Christopher A Demitrius, Christopher Downey, PhD, Christopher Janik, Christopher K Vantwuyver, Christopher M Elliott, Chunsheng Cai, PhD, Clinton V Giustra, Constance Desimone, Courtney N Long, Craig A Garmendia, Craig T Rybus, Cynthia F Kleppinger, MD, Dana A Razzano, Danielle S Pearson, Darin S Wiegers, Daryl A Dewoskin, David M Lamoureux, David P Vanhouten, David R Heiar, Dawn C Olenjack, Dawn M Braswell, Deborah A Greco, Diane C Thibodeau, Dien N Nguyen, Dolores Harper, Douglas S Joslin, Dr. Sriram Subramaniam, PhD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edward J Janik, Ekaterina Allen, Elise L Mcdevitt, Elizabeth B Griffin, Elizabeth Ll Edwards, Ellen P Madigan, Emily J Schramm, Eric C Schmitt, Erich P Garger, Erin P Conlin, Felix Maldonado, Frank J Koch, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Garry H Stewart, Gary J Hagan, Gena M Mckahan, Gene D Arcy, George T Allen, Jr, Gerald N Mcgirl, DDS, Gerard D Difiore, Gunther Boekhoudt, PhD, Haley H Seymour, Hang N Guo, Hien Albright, Himanshu Gupta, PhD, Intkhab H Wahla, Iram R Hassan, PhD, Isaac K Carney, Jackson Y See, James H Tanner, James P Finn, James W Whitney, Jamie S Mathews, Janete F Guardia, Jason A Rossi, Jay M Patria, Jayaleka J Amarasinghe, Jee Chung, PhD, Jeffrey J Thibodeau, Jeffrey S Buckser, Jessica D Spellman, Jessica I Newman, Joanne M Schlossin, John A Sciacchitano, John B Crowe, John D White, John J Thibodeau, John L Zaccone, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan G Matrisciano, Jonee J Mearns, Jose A Torres, Joseph B Cascio, Joseph Foley, Joseph H Procopio, Jr, Joseph T Frost, Joshua L Gibbs, Joy P Matthias, Joyce A Kellett, Joyce A Rockwell, Joyce A Williams, Juan C Gonzalez Rivera, Julie D Bringger, Justine M Corson, Ka L Wong, Kara A Scheibner, PhD, Karen L Kosar, Karen M Cooper, Karen Mcnabb Noon, Kathleen A Sousa, Kathleen E Mcafoose, Kathleen M Curry, Kathleen R Jones, PhD, Kathryn A Krentz, Kenneth H Williams, Kent A Conforti, Kimberly J Langello, Kip J Hanks, Kristina J Donohue, Kyle J Spencer, Lauren M Lawrance, LCDR Debra Emerson, Leah M Andrews, Leo B Zadecky, Liz M Otero, Lorayne A Mcguinness, Louis Christy, Lynne M Dwyer, Margaret E Walsh, Margaret M Sands, Maria Pkelly Doggett, MBA, Mark A Heard, Mark E Farrell, Mark R Mcclain, Martha T Olone, Martin J Guardia, Mary Jeanet Mcgarry, Mary P Murphy, Maryam Tabatabaie, Matthew C Watson, Maxwell Van Tassell, PhD, Maya M Davis, Mclaughlin, Megan A Haggerty, Melissa N Gregorio, Meredith L Miller, Miah Jung, Michael E Marcarelli, Michael F Skelly, PhD, Michael J Casey, Michael L Casner, Michael P Anthony, Michael P Sweeney, Michelle J Hines, Michelle Rfrazier Jessen, PhD, Mikayla K Deardorff, Monique C Lo, Mutahar S Shamsi, Myla D Chapman, Nabil Nakhoul, Nadeem I Chaudhry, Nailing Zhang, Nasser Yazdani, DVM, MPH, Nealie C Newberger, Nicholas E Stuhr, Nichole B Murphy, Nicola M Fenty Stewart, Nina Yang, Ogechi C Nna, Osama A Khatib, Pamela L Lee, Pamela L Ogonowski, Paraluman S Leonin, Patricia F Hughes, PhD, Patrick M Regan, Paul Lihong Yeh, PhD, Paul P Geraci, Paula A Trost, Paula M Laplant, Peter R Lenahan, Philip H Lafleur, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Priscilla M Pastrana, Rachael O Oyewole, Ramcharan S Khalsa, Ramon E Martinez, Rapti D Madurawe, Rebecca A Coleman, Remal, Richard F Hapke, Richard H Penta, Richard L Friedman, Richard L Licari, Richard W Thornton, Robert D Ogan, Robert E Moncayo, Robert J Martin, Robert O'brian, Rory K Geyer, Rupa Pradhan, Ruth A Williams, Sandra P White, Sara M Onyango, Scott B Laufenberg, Scott C Lute, Sean M Tessicini, Sean R Marcsisin, Sereen Gmorgan Murray, Seth A Mailhot, Sharon K Gershon, Shawn M Bogdan, Sherri N Rohlf, MD, Simone E Pitts, Slater K Bartlett, Sripal R Mada, PhD, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen R Souza, Steven M Ferrara, Sunita Pandey, Susan D Yuscius, Susanne M Richardson, MS RAC, Suzanne M Healy, Tania K Mercado, Teddy Tom, Thomas Cote, Thomas H Jenkins, Thomas J Arista, Thomas J Kelly, Thomas J Murphy, Thomas O Morgan, Thomas Siebertz, Thomas W Nerney, Thomas W Nojek, Timothy M Glod, Troy R Petrillo, Victor J Gangi, Victoria M Daddeo, Victoria Taylor, Walter N Lange, Wayne E Seifert, Wendy A Johnecheck, William K Dagley, Xiaokuang Lai, PhD, Yanming An, PhD, Yuanyuan Li, Zhongren Wu

Michelle M Noe Varga's Documents

Publish Date Document Type Title
September, 2003 EIR The Superior Nut Company, Inc. - EIR, 2003-09-30
June, 2009 FDA 483 Pfizer Inc. - Form 483, 2009-06-03
November, 2007 FDA 483 Tedor Pharma Inc. - Form 483, 2007-11-08
July, 2014 FDA 483 Response Emerson Hospital Human Rights Committee - Form 483R, 2014-08-04
April, 2004 EIR First Boston Pharma LLC - EIR, 2004-04-20
July, 2014 EIR Emerson Hospital Human Rights Committee - EIR, 2014-07-24
January, 2010 FDA 483 Shire Human Genetics Therapies, Inc. - Form 483, 2010-01-07
September, 2008 FDA 483 Response Ameridose, LLC - Form 483R, 2008-12-09
January, 2007 FDA 483 Dr. Remo Panaccione-University of Calgary - Form 483, 2007-01-26
April, 2008 FDA 483 Response Charles J. Cote, MD - Form 483R, 2008-04-30
September, 2010 EIR Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2010-09-01
June, 2012 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2012-06-06
October, 2013 EIR Moussa C. Mansour, MD - EIR, 2013-10-15
April, 2008 EIR Charles J. Cote, MD - EIR, 2008-04-30
March, 2005 EIR Stephen Rossner - EIR, 2005-03-10
June, 2009 EIR Pfizer Inc. - EIR, 2009-06-03
March, 2005 FDA 483 Stephen Rossner - Form 483, 2005-03-10
April, 2008 FDA 483 Charles J. Cote, MD - Form 483, 2008-04-30
May, 2014 FDA 483 Robert J. Weiss, M.D. - Form 483, 2014-05-12
May, 2014 EIR Robert J. Weiss, M.D. - EIR, 2014-05-12
September, 2010 FDA 483 Response Boehringer Ingelheim Pharmaceuticals, Inc. - Form 483R, 2010-09-14
October, 2013 FDA 483 Response Moussa C. Mansour, MD - Form 483R, 2013-11-04
June, 2012 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2012-05-07
September, 2003 FDA 483 Response The Superior Nut Company, Inc. - Form 483R, 2003-10-07
March, 2015 FDA 483 Andrea L. D. Orsey, M.D. - Form 483, 2015-03-24
September, 2008 EIR Ameridose, LLC - EIR, 2008-09-18
July, 2014 FDA 483 Emerson Hospital Human Rights Committee - Form 483, 2014-07-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more